Keyphrases
Netherlands
100%
Cost-effectiveness
83%
Dutch
47%
Quality-adjusted Life Years
33%
Budget Impact
25%
Incremental Cost-effectiveness Ratio
24%
Health Impact
22%
Economic Evaluation
22%
Indonesia
22%
Multiple Myeloma
21%
Newborn Screening
21%
Multi-stakeholder
21%
Systematic Literature Review
21%
Health-related Quality of Life
20%
Quality of Life
19%
Cost-effectiveness Analysis
18%
Finnish Diabetes Risk Score
16%
Vaccination
16%
Patient-Reported Outcomes Measurement Information System (PROMIS)
15%
Patient Engagement
15%
Quadrivalent
14%
Infectious Diseases
14%
E-coaching
13%
Multiple Myeloma Patients
13%
Influenza
13%
Diabetes
13%
Kidney Disease
13%
Economic Impact
13%
Indonesian Population
13%
Cardiovascular Disease
12%
Recently Diagnosed
12%
Patient-reported Outcomes
12%
Patient-reported Experience Measures
12%
Reimbursement
12%
High Dose
12%
Influenza Vaccination
12%
Randomized Controlled Trial
11%
Health Outcomes
11%
Cost Savings
10%
National Immunization Program
10%
Hospital Intervention
10%
Rotavirus Vaccine
10%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
10%
Octreotide Long-acting Release
10%
Orphan Drugs
10%
Lutetium
10%
Kidney Disease Quality of life-36
10%
Hemodialysis
10%
Dialysis Patients
10%
Midgut Neuroendocrine Tumor
10%
Medicine and Dentistry
Cost-Effectiveness Analysis
75%
Health Care Cost
68%
Quality Adjusted Life Year
42%
Quality of Life
38%
Systematic Review
32%
Disease
23%
Diabetes
23%
Drug Megadose
21%
Multiple Myeloma
21%
Nephropathy
21%
Lifespan
17%
Randomized Controlled Trial
17%
Patient-Reported Outcome
14%
Cardiovascular Disease
13%
Base
12%
Population
12%
Influenza Vaccination
12%
Cardiovascular System
12%
Psychometry
10%
CYP2C19
10%
Newborn Screening
10%
Spinal Muscular Atrophy
10%
Cost of Illness
10%
Meningococcal Disease
10%
Neisseria meningitidis
10%
Albuminuria
10%
Interstitial Lung Disease
10%
Nintedanib
10%
Respiratory Tract Infection
10%
Influenza Vaccine
10%
Disease Management
10%
Dysglycemia
10%
Seasonal Influenza
10%
Baloxavir Marboxil
10%
Antivirus Agent
10%
Remote Patient Monitoring
10%
Non Small Cell Lung Cancer
10%
Rapid Diagnostic Test
10%
e-Health
10%
Infection
10%
Immune Deficiency
10%
Drug Use
10%
Health Care
10%
Orphan Drug
10%
Wart Virus
10%
Cervical Cancer
10%
Patient Care
10%
Cross Sectional Study
10%
Primary Health Care
10%
Acute Heart Infarction
10%
